Stephen Kanes

Insider Reports History

Entity
Individual
Location
215 First Street, Cambridge, MA
Signature
/s/ Gregory Weinhoff, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Kanes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Medical Officer Common Stock 13.5K $18.3K $1.36 Oct 19, 2021 Direct
Centessa Pharmaceuticals plc Chief Medical Officer Share Option (right to buy) 500K Feb 3, 2025 Direct

Insider Reports Filed by Stephen Kanes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNTA Centessa Pharmaceuticals plc Feb 3, 2025 1 $0 4 Feb 4, 2025 Chief Medical Officer
CNTA Centessa Pharmaceuticals plc Jan 6, 2025 0 $0 3 Jan 16, 2025 Chief Medical Officer
SAGE Sage Therapeutics, Inc. Oct 19, 2021 2 -$45.1K 4 Oct 21, 2021 Chief Medical Officer
SAGE Sage Therapeutics, Inc. Jun 15, 2021 2 -$58.9K 4 Jun 17, 2021 Chief Medical Officer